Company profile
Poplar Therapeutics
Toward Zero. Beyond Limits.
- Industry
- Biotechnology Research
- Employees
- 12
- Headquarters
- Boston, MA
- LinkedIn followers
- 1,245
- Office locations
- 1
Poplar Therapeutics company summary
Poplar Therapeutics is a company in the Biotechnology Research industry, headquartered in Boston, MA. On LinkedIn the company has around 12 employees and 1,245 followers.
What technology does Poplar Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Poplar Therapeutics
Poplar Therapeutics is a clinical-stage immunology company developing a new class of anti-IgE therapy to challenge convention in allergic disease treatment. Its lead program, PHB-050, is a next-generation anti-IgE antibody with a unique triple-action design currently being studied in atopic diseases. Poplar is pursuing the bold idea that IgE can be rapidly driven toward zero, with the goal of helping people with IgE-mediated conditions move from fear toward freedom.
Where is Poplar Therapeutics located?
Poplar Therapeutics lists 1 location.
Compare companies similar to Poplar Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Poplar Therapeutics poplartx.com | Biotechnology Research | 12 | - | Boston, MA |
Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Poplar Therapeutics
What does Poplar Therapeutics do?
Poplar Therapeutics is a clinical-stage immunology company developing a new class of anti-IgE therapy to challenge convention in allergic disease treatment. Its lead program, PHB-050, is a next-generation anti-IgE antibody with a unique triple-action design currently being studied in atopic diseases. Poplar is pursuing the bold idea that IgE can be rapidly driven toward zero, with the goal of helping people with IgE-mediated conditions move from fear toward freedom.
How many employees does Poplar Therapeutics have?
Poplar Therapeutics has around 12 employees on LinkedIn.
Where is Poplar Therapeutics headquartered?
Poplar Therapeutics is headquartered in Boston, MA.
Build a lead list from companies like Poplar Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.